 |
 |
|
|
|
| Allopurinol |
 |
| white powder |
 |
| 315-30-0 |
 |
Use of allopurinol and its metabolites do not xanthine, both inhibition of xanthine oxidase interest, and thus make uric acid synthesis is blocked, reducing blood uric acid concentrations, reduce urate calm in the bones, joints and kidneys. Clinical for gout, gouty nephropathy. Pregnant women with caution
Some patients may rash, gastrointestinal reactions and liver damage and hematopoietic systems, such as elevated transaminases and leukopenia
6 with anticancer drugs - mercaptopurine when combined, to 6 - mercaptopurine dose is reduced to a constant 1/4. More water, in order to facilitate uric acid excretion.
Use of anti-gout drugs. For primary or secondary increase in serum uric acid of various diseases, such as gout, acute or chronic leukemia.
Use of anti-gout drug, used to treat gout, gouty nephropathy |
 |
Allopurinol Basic information
Product Name: Allopurinol
Synonyms: TIMTEC-BB SBB004202
ISOPURINOL
LABOTEST-BB LT00244764
HPP
1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-OL
AKOS BBS-00005290
ALLPURINOL
AKOS BBS-00002073
CAS: 315-30-0
MF: C5H4N4O
MW: 136.11
EINECS: 206-250-9 |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
